This article covers PR and communications strategy only. It contains no medical, legal or regulatory advice, and nothing here should be read as such. A health or healthtech company's own regulatory and legal counsel should confirm any specific claim before it goes public.
By pitching a real news hook, a funding round, a new health system partnership, a regulatory clearance, rather than a category description, and by backing any outcome claim with the actual data behind it, not a rounded-up headline number. Health tech reporters cover a beat that attracts more hype than almost any other, so they filter hardest for the pitches that skip the buzzwords and show the work.
What's actually happening in digital health funding right now?
A rebound, concentrated in fewer, bigger deals. Rock Health's H1 2026 funding report found that US digital health startups raised 7.4 billion dollars across 244 deals in the first half of 2026, up from 6.4 billion dollars on roughly as many deals a year earlier. The median deal size climbed to 14 million dollars, the highest Rock Health has tracked since 2022, and 19 companies closed 20 deals of 100 million dollars or more, absorbing 45 percent of all capital invested in just over 8 percent of the deals.
That concentration matters for anyone pitching a story. Mental health held its position as the top-funded clinical category for a seventh straight year, with weight management and obesity care close behind. If your company sits in a crowded, well-funded category, a reporter has already covered three companies like yours this quarter, and your pitch needs a reason it isn't the fourth.
What actually counts as news to a health tech reporter?
A specific hook, not a description of the product. STAT News, one of the most read outlets on this beat, says it wants "smart, compelling, original reporting that takes readers inside the world of health, medicine and scientific discovery," and explicitly avoids consumer wellness fluff and stories that will be widely covered everywhere else. MedCity News has made the same point about its own inbox: a pitch without a clear hook, a fundraising round, a new partnership, a new customer, or something else genuinely newsworthy, does not get coverage just because the product is interesting.
The practical filter is the same one that applies across SaaS and fintech pitches: name the thing that happened, not the category you operate in.
Why does overclaiming backfire so badly in this industry?
Because health reporters ask for the underlying data, and most companies can't produce it. The same MedCity reporter's complaint is specific: when a pitch claims a product "reduces burnout by 75 percent," the reporter wants the actual metrics behind that number, the sample size, the methodology, what was measured and over what period. A press release stat that can't survive that question shouldn't be in the press release.
This is also where buzzwords do real damage. Vague language like "uniquely innovative" or "reimagining care" does not read as ambition to a reporter who covers this beat daily. It reads as a company that doesn't have a specific claim to make, and the pitch gets filed with the dozens of others that said the same thing that week.
What else, besides funding, counts as a real hook in this category?
Consolidation and clinical traction, not just the next raise. Rock Health's H1 2026 report also tracked 115 digital health acquisitions in the first half of the year, the busiest pace since the third quarter of 2021, with 71 of those happening in the second quarter alone. An acquisition pitch has a built-in hook a funding round doesn't: what capability the acquirer gains, which customers or data the deal brings together, and why now. The same report noted individual raises worth naming specifically when they happened, Talkiatry's 210 million dollar round and Grow Therapy's 150 million dollar round both landed in the mental health category that has topped digital health funding for seven straight years, which is itself useful context for any company in or adjacent to that space pitching its own news.
A public filing is a hook too. Oura's S-1 was the first digital health IPO filing of 2026, and public digital health companies reporting strong quarterly growth, Hinge Health's 47 percent year-over-year revenue increase in its first public quarter among them, give reporters a reason to write about the category generally, which is the moment a smaller company's news in the same space is likeliest to get read.
Which outlets actually cover this beat?
A short list of specialists who write about digital health specifically, not general tech or business press that covers it occasionally. STAT News and MedCity News, both already covered above, anchor the beat in the US, alongside Fierce Healthcare and HIT Consultant for provider-side and payer-side news. The right target changes by what the story actually is: a clinical partnership story suits a different reporter than a payer contract story, and pitching the wrong one at the right outlet wastes the one shot a strong hook deserves. The same discipline that works for SaaS pitches, a short list of five to ten journalists who write about exactly this category, applies here with an even narrower list, since the health tech trade press is smaller than general B2B tech coverage.
How should a company talk about FDA clearance without misleading anyone?
Precisely, because the two terms are not interchangeable. The FDA clears a device under a 510(k) submission when it demonstrates substantial equivalence to an existing, already-marketed device; no independent clinical proof of safety or effectiveness is required for that pathway. The FDA approves a device under a PMA, premarket approval, only after reviewing independent clinical evidence of safety and effectiveness, a higher bar reserved mostly for higher-risk Class III devices. A company that says "FDA-approved" about a 510(k)-cleared product is making a factually wrong claim, and a journalist or a competitor who checks the FDA's own database will find the discrepancy immediately.
Get this right in every release and every interview answer. It's a small distinction with an outsized reputational cost if a reporter catches it wrong after publication, and it is the kind of error that undermines everything else the company has said.
Does patient data and privacy come up in the pitch?
Often, and it's worth addressing before a reporter asks. Any company handling patient health information operates inside a regulatory framework that a health tech reporter will assume you understand; being able to describe, in plain terms, what data you collect and how it's protected is part of being taken seriously on this beat. This is a communications point, not a compliance one: a company's actual HIPAA posture and data practices should come from its own compliance and legal counsel, not from a press release written to sound reassuring.
What should the pitch actually include?
A short, specific case for why now. STAT's own guidance to writers asks for 300 to 600 words that convey what's new, give context, and name who's available to talk. That length and structure work just as well for a PR pitch to a staff reporter: say what happened, why it matters to this outlet's readers specifically, and who can speak to it this week, not next month. MedCity's reporter is explicit that executives need to be available within a couple of days, not weeks later, because health reporters work on tight deadlines and a slow company gets dropped from the story.
Keep follow-ups to one or two. A reporter who hasn't responded after a second note has likely passed, and further emails read as pressure rather than persistence. If the hook is a funding round, treat the raise itself as the least interesting part of the pitch, and lead instead with what the money changes: a new clinical team, a new care setting, access to a population the company couldn't reach before.
How do you know if any of this actually worked?
Not by counting how many outlets ran the release. The same advertising-value thinking that distorts PR measurement everywhere else distorts it here too, and our guide to measuring whether PR is actually working covers why AMEC's Barcelona Principles reject coverage-counting in favor of outcomes tied to the original goal: did the right investors see it, did the right health system reach out, did the hire you announced get the applicants you needed. A health tech story that runs in one outlet a hospital system's leadership actually reads is worth more than ten that don't.
The direct answer, for anyone who read this far
Healthtech and digital health startups earn coverage by pitching a specific, dated hook, a funding round, a clearance, a partnership, rather than a category pitch, and by having the actual data ready when a reporter asks where a stated outcome number came from. Get the difference between FDA clearance and approval right every time, keep buzzwords out of the pitch, and make sure an executive can talk within days, not weeks, once the story is moving.
If your next funding round, clearance or launch needs a pitch built around what health reporters actually ask for, request a quotation and we'll build it with you.
